S&P 500   3,585.62
DOW   28,725.51
QQQ   267.26
EV Battery Maker Freyr Set For Major Global Expansion
Sell every Stock except ONE (Ad)
Want to Increase Your Conversion Rates? This Is the Biggest Threat to Your Success.
Russia accused of 'kidnapping' head of Ukraine nuclear plant
Sell every Stock except ONE (Ad)
MarketBeat: Week in Review 9/26 – 9/30
EU chief: New Greece-Bulgaria gas pipeline 'means freedom'
In 20 years, this little-known trader didn’t have a single losing year… (Ad)
Danish Energy Agency says Nord Stream 2 gas pipeline under Baltic Sea appears to have stopped leaking gas
Montana site fouled by copper smelter to get final cleanup
S&P 500   3,585.62
DOW   28,725.51
QQQ   267.26
EV Battery Maker Freyr Set For Major Global Expansion
Sell every Stock except ONE (Ad)
Want to Increase Your Conversion Rates? This Is the Biggest Threat to Your Success.
Russia accused of 'kidnapping' head of Ukraine nuclear plant
Sell every Stock except ONE (Ad)
MarketBeat: Week in Review 9/26 – 9/30
EU chief: New Greece-Bulgaria gas pipeline 'means freedom'
In 20 years, this little-known trader didn’t have a single losing year… (Ad)
Danish Energy Agency says Nord Stream 2 gas pipeline under Baltic Sea appears to have stopped leaking gas
Montana site fouled by copper smelter to get final cleanup
S&P 500   3,585.62
DOW   28,725.51
QQQ   267.26
EV Battery Maker Freyr Set For Major Global Expansion
Sell every Stock except ONE (Ad)
Want to Increase Your Conversion Rates? This Is the Biggest Threat to Your Success.
Russia accused of 'kidnapping' head of Ukraine nuclear plant
Sell every Stock except ONE (Ad)
MarketBeat: Week in Review 9/26 – 9/30
EU chief: New Greece-Bulgaria gas pipeline 'means freedom'
In 20 years, this little-known trader didn’t have a single losing year… (Ad)
Danish Energy Agency says Nord Stream 2 gas pipeline under Baltic Sea appears to have stopped leaking gas
Montana site fouled by copper smelter to get final cleanup
S&P 500   3,585.62
DOW   28,725.51
QQQ   267.26
EV Battery Maker Freyr Set For Major Global Expansion
Sell every Stock except ONE (Ad)
Want to Increase Your Conversion Rates? This Is the Biggest Threat to Your Success.
Russia accused of 'kidnapping' head of Ukraine nuclear plant
Sell every Stock except ONE (Ad)
MarketBeat: Week in Review 9/26 – 9/30
EU chief: New Greece-Bulgaria gas pipeline 'means freedom'
In 20 years, this little-known trader didn’t have a single losing year… (Ad)
Danish Energy Agency says Nord Stream 2 gas pipeline under Baltic Sea appears to have stopped leaking gas
Montana site fouled by copper smelter to get final cleanup
NASDAQ:MBII

Marrone Bio Innovations - MBII Stock Forecast, Price & News

$0.80
0.00 (0.00%)
(As of 09/7/2022)
Add
Compare
Today's Range
$0.80
$0.80
50-Day Range
$0.80
$0.80
52-Week Range
$0.55
$1.55
Volume
38 shs
Average Volume
919,497 shs
Market Capitalization
$145.56 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$1.90

Marrone Bio Innovations MarketRank™ Forecast

Analyst Rating
Moderate Buy
2.50 Rating Score
Upside/​Downside
138.1% Upside
$1.90 Price Target
Short Interest
N/A
Dividend Strength
N/A
Sustainability
-11.74
Upright™ Environmental Score
News Sentiment
0.12mentions of Marrone Bio Innovations in the last 14 days
Based on 5 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
Growing
From ($0.06) to ($0.02) Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.65 out of 5 stars

Basic Materials Sector

151st out of 167 stocks

Agricultural Chemicals Industry

9th out of 10 stocks

MBII stock logo

About Marrone Bio Innovations (NASDAQ:MBII) Stock

Marrone Bio Innovations, Inc. discovers, develops, and sells biological products for crop protection, crop health, and crop nutrition. Its products include Emergen, Foramin, Foramin ST, Optima, Takla, Pacesetter, Ympact, UBP, and UBP ST for increasing crop health, yield, and quality; Grandevo, a bioinsecticide that controls sucking and chewing insects through feeding; Haven, a plant health product to reduce sun stress and dehydration; Jet-Ag and Jet-Oxide peroxyacetic acid sanitizers that prevent, suppress, eliminate, and control algae, fungi, and bacterial diseases in agriculture and horticultural industries; and Majestene, a bionematicide to control soil-dwelling nematodes and certain soil borne insects. The company also offers Regalia and Stargus, which protects against fungal and bacterial diseases and enhances yields/quality; Venerate, a bioinsecticide that controls chewing and sucking insects and mites; and Zelto, a bionematicide that protects turf, including golf course fairways and greens, and promotes turf health by enhancing plant and root health. It provides its products directly through sales force, as well as through distributors and other commercial partners. The company formerly known as Marrone Organic Innovations, Inc. Marrone Bio Innovations, Inc. was incorporated in 2006 and is headquartered in Raleigh, North Carolina.

Receive MBII Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Marrone Bio Innovations and its competitors with MarketBeat's FREE daily newsletter.

MBII Stock News Headlines

MBI: Body found in Forrest Co. identified
Marrone name goes away in sale to Bioceres
Mid-Afternoon Market Update: Nasdaq Down 3%; Accolade Shares Slide
Preview: Marrone Bio Innovations's Earnings
See More Headlines
Receive MBII Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Marrone Bio Innovations and its competitors with MarketBeat's FREE daily newsletter.

MBII Company Calendar

Last Earnings
11/10/2021
Today
10/01/2022
Fiscal Year End
12/31/2022

Industry, Sector and Symbol

Industry
Agricultural chemicals
Sub-Industry
N/A
Current Symbol
NASDAQ:MBII
Fax
N/A
Employees
153
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$1.90
High Stock Price Forecast
$2.50
Low Stock Price Forecast
$1.30
Forecasted Upside/Downside
+138.1%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.50
Research Coverage
2 Analysts

Profitability

Net Income
$-16,550,000.00
Pretax Margin
-47.12%

Debt

Sales & Book Value

Annual Sales
$44.31 million
Book Value
$0.17 per share

Miscellaneous

Free Float
173,259,000
Market Cap
$145.56 million
Optionable
Not Optionable
Beta
0.36

Key Executives

  • Mr. Kevin R. Helash (Age 57)
    CEO & Director
    Comp: $416.64k
  • Dr. Pamela G. Marrone Ph.D. (Age 65)
    Founder, Advisor & Non-Employee Director
    Comp: $254.58k
  • Ms. Linda V. Moore (Age 75)
    Chief Compliance Officer, Chief Legal Officer & Sec.
    Comp: $316.74k
  • Mr. LaDon Johnson CPA
    CPA, Interim Chief Financial Officer
  • Dr. Amit Vasavada Ph.D. (Age 67)
    Sr. VP of Research Devel. & Chief Technical Officer
  • Andre Trepanier
    Director of Marketing
  • Mr. Barner Jones
    Director of National Sales & Account Management
  • Mr. Matti Tiainen (Age 33)
    Sr. VP of International Sales
  • Mr. Keith J. Pitts (Age 58)
    Sr. VP of Regulatory & Gov. Affairs and Chief Sustainability Officer













MBII Stock - Frequently Asked Questions

Should I buy or sell Marrone Bio Innovations stock right now?

2 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Marrone Bio Innovations in the last year. There are currently 1 hold rating and 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "buy" MBII shares.
View MBII analyst ratings
or view top-rated stocks.

What is Marrone Bio Innovations' stock price forecast for 2022?

2 brokers have issued 12 month price objectives for Marrone Bio Innovations' stock. Their MBII share price forecasts range from $1.30 to $2.50. On average, they predict the company's share price to reach $1.90 in the next twelve months. This suggests a possible upside of 138.1% from the stock's current price.
View analysts price targets for MBII
or view top-rated stocks among Wall Street analysts.

How have MBII shares performed in 2022?

Marrone Bio Innovations' stock was trading at $0.7202 at the beginning of 2022. Since then, MBII stock has increased by 10.8% and is now trading at $0.7981.
View the best growth stocks for 2022 here
.

How were Marrone Bio Innovations' earnings last quarter?

Marrone Bio Innovations, Inc. (NASDAQ:MBII) posted its earnings results on Wednesday, November, 10th. The basic materials company reported ($0.03) earnings per share for the quarter, meeting analysts' consensus estimates of ($0.03). The basic materials company earned $9.86 million during the quarter, compared to analysts' expectations of $10.79 million. Marrone Bio Innovations had a negative trailing twelve-month return on equity of 70.87% and a negative net margin of 47.07%. During the same quarter in the previous year, the business earned ($0.04) earnings per share.

What other stocks do shareholders of Marrone Bio Innovations own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Marrone Bio Innovations investors own include Ekso Bionics (EKSO), Matinas BioPharma (MTNB), Bionano Genomics (BNGO), KushCo (KSHB), Enerplus (ERF), ADMA Biologics (ADMA), Great Panther Mining (GPL), OrganiGram (OGI), Aeterna Zentaris (AEZS).

What is Marrone Bio Innovations' stock symbol?

Marrone Bio Innovations trades on the NASDAQ under the ticker symbol "MBII."

How do I buy shares of Marrone Bio Innovations?

Shares of MBII stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Marrone Bio Innovations' stock price today?

One share of MBII stock can currently be purchased for approximately $0.80.

How much money does Marrone Bio Innovations make?

Marrone Bio Innovations (NASDAQ:MBII) has a market capitalization of $145.56 million and generates $44.31 million in revenue each year. The basic materials company earns $-16,550,000.00 in net income (profit) each year or ($0.12) on an earnings per share basis.

How many employees does Marrone Bio Innovations have?

The company employs 153 workers across the globe.

How can I contact Marrone Bio Innovations?

Marrone Bio Innovations' mailing address is 1540 Drew Avenue, Davis CA, 95618. The official website for the company is www.marronebioinnovations.com. The basic materials company can be reached via phone at (530) 750-2800 or via email at ir@marronebio.com.

This page (NASDAQ:MBII) was last updated on 10/1/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.